Edwards Lifesciences Corporation

NYSE:EW Stock Report

Market Cap: US$57.3b

Edwards Lifesciences Past Earnings Performance

Past criteria checks 3/6

Edwards Lifesciences has been growing earnings at an average annual rate of 15.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 9% per year. Edwards Lifesciences's return on equity is 20.8%, and it has net margins of 23.4%.

Key information

15.5%

Earnings growth rate

16.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate9.0%
Return on equity20.8%
Net Margin23.4%
Next Earnings Update25 Apr 2024

Recent past performance updates

Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Feb 21
Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Recent updates

Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Feb 21
Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)

Feb 14

Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Feb 08
Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly

Jan 28
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly

The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing

Jan 14
The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing

Edwards Lifesciences: Undervalued With A Substantial Upside Potential

Jan 09

Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Dec 31
Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Dec 17
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets

Oct 26

Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Oct 23
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Oct 09
Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Sep 26
Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Sep 11
A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences: Rising Dominance In Structural Heart Disease

Aug 21

Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Jul 16
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Jun 30
Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Jun 15
Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed

Jun 12

Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

May 31
Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet

Apr 03
Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet

What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Mar 22
What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)

Mar 10
Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Feb 26
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges

Feb 06

Edwards Lifesciences slips as Piper downgrades on challenging setup

Jan 30

Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity

Jan 18

Edwards Lifesciences: Catalysts For 2023 And Beyond

Dec 30

Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Dec 28
Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Dec 16
Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences CEO Michael Mussallem to retire

Dec 08

Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Dec 04
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Nov 22
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences down 11% after Q3 misses, revised 2022 EPS guidance

Oct 27

Revenue & Expenses Breakdown
Beta

How Edwards Lifesciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:EW Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 236,0051,4021,8231,072
30 Sep 235,8191,4311,7551,034
30 Jun 235,6571,3901,692997
31 Mar 235,5011,4891,633978
31 Dec 225,3821,5221,567945
30 Sep 225,3641,4591,581946
30 Jun 225,3551,4551,568950
31 Mar 225,3571,5391,534925
31 Dec 215,2331,5031,494903
30 Sep 215,0951,4771,409866
30 Jun 214,9251,4621,351824
31 Mar 214,4748511,252780
31 Dec 204,3868231,229761
30 Sep 204,3697941,235759
30 Jun 204,3227441,234759
31 Mar 204,4841,1081,268769
31 Dec 194,3481,0471,242753
30 Sep 194,1527741,182722
30 Jun 193,9647251,146688
31 Mar 193,8217651,113650
31 Dec 183,7237221,088622
30 Sep 183,6347121,080606
30 Jun 183,5496571,055587
31 Mar 183,4475601,023567
31 Dec 173,435584984553
30 Sep 173,315745948521
30 Jun 173,232716933491
31 Mar 173,150657918469
31 Dec 162,964570905442
30 Sep 162,867552892426
30 Jun 162,743528875414
31 Mar 162,601515860399
31 Dec 152,494495851383
30 Sep 152,441463852369
30 Jun 152,433440862356
31 Mar 152,391874863347
31 Dec 142,323811858347
30 Sep 142,241777822341
30 Jun 142,129759777338
31 Mar 142,071306748329
31 Dec 132,046389733323
30 Sep 132,020405724319
30 Jun 131,972398714309
31 Mar 131,937372710303

Quality Earnings: EW has high quality earnings.

Growing Profit Margin: EW's current net profit margins (23.4%) are lower than last year (28.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EW's earnings have grown by 15.5% per year over the past 5 years.

Accelerating Growth: EW's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: EW had negative earnings growth (-7.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (8.7%).


Return on Equity

High ROE: EW's Return on Equity (20.8%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.